Skip to main content

Table 3 Adverse events

From: A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood

Adverse event Triheptanoin
(n = 6)
Placebo
(n = 8)
WO
(n = 5)
Infection 3 (50) 5 (63) 3 (60)
Digestive disorders 1 (17) 2 (25) 0 (0)
Others 2 (33) 1 (13) 2 (40)
  1. Data are n (%). The denominator is the number of trial participants who had adverse events. Abbreviation: AE adverse events, WO washout period